Intervention psychosociale

Sujet

A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis

Publications /

Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D. Psychiatry Res. 2025 Aug;350:116553. doi: 10.1016/j.psychres.2025.116553. Epub 2025 May 17. PMID: 40450961

A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis Lire la suite »

A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing

Publications /

Côté J, Auger P, Chicoine G, Cheng J, Cossette S, Fontaine G, Genest C, Lal S, Lapierre J, Pagé MG, Maheu-Cadotte MA, Rouleau G, Vinette B, Jutras-Aswad D. JMIR Form Res. 2025 Jun 23;9:e71924. doi: 10.2196/71924. PMID: 40550117; PMCID: PMC12235202.

A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing Lire la suite »

Rethinking the psychosis spectrum: A meta-analysis unveils a nonlinear discontinuity in verbal learning deficits between at-risk conditions and psychotic disorders

Publications /

Florence Pilon, Charles‑Édouard Giguère, Stéphane Potvin Eur Psychiatry. 2025 Sep 1;68(1):e122. doi: 10.1192/j.eurpsy.2025.10094. PMID: 40887798; PMCID: PMC12438976 CONSULTER

Rethinking the psychosis spectrum: A meta-analysis unveils a nonlinear discontinuity in verbal learning deficits between at-risk conditions and psychotic disorders Lire la suite »

A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study

Publications /

Bach P, Le Foll B, Davidson S, de Kiewit A, Bakouni H, Poulin G, Ghosh M, Jutras-Aswad D. Contemp Clin Trials. 2025 Jun;153:107916. doi: 10.1016/j.cct.2025.107916. Epub 2025 Apr 13. PMID: 40233849

A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study Lire la suite »

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives

Publications /

Bédard K, Boisvert I, Rochette M, Racine E, Martel-Laferrière V. BMC Infect Dis. 2025 Feb 14;25(1):221. doi: 10.1186/s12879-025-10617-y. PMID: 39953410; PMCID: PMC11829365. CONSULTER

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives Lire la suite »

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial

Publications /

Conrod P, Stewart SH, Seguin J, Pihl R, Masse B, Spinney S, Lynch S. Am J Psychiatry. 2025 Jan 15:appiajp20240042. doi: 10.1176/appi.ajp.20240042. Epub ahead of print. PMID: 39810554

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial Lire la suite »

MENU

CONTACT

Centre de Recherche du CHUM

900 rue St-Denis Montréal (Québec) H2X 0A9 - R06

Téléphone

+1 514 890-8000 ext. 30906

Courriel

quebec@crism.ca

Linkedin
Inscription à l'infolettre
Devenir membre du pôle

Tous droits réservés | © Copyright 2025 | ICRIS Québec